{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:54:32Z","timestamp":1772556872324,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["RED-00053-21"],"award-info":[{"award-number":["RED-00053-21"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/50928-2"],"award-info":[{"award-number":["2014\/50928-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["465687\/2014-8"],"award-info":[{"award-number":["465687\/2014-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303547\/2023-5"],"award-info":[{"award-number":["303547\/2023-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13346-025-02001-9","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:22:42Z","timestamp":1761063762000},"page":"1319-1331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of AAV\/polyketal chimeric nanoparticles for ocular gene transduction using an animal model"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-8757","authenticated-orcid":false,"given":"Brenda Fernanda Moreira","family":"Castro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3806-8145","authenticated-orcid":false,"given":"Margaret","family":"Lugin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0847-3737","authenticated-orcid":false,"given":"Maria Carolina Andrade","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3878-5192","authenticated-orcid":false,"given":"Marina Fran\u00e7a","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1161-8936","authenticated-orcid":false,"given":"Armando","family":"Silva-Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4086-6995","authenticated-orcid":false,"given":"Young Jik","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8068-5211","authenticated-orcid":false,"given":"Silvia Lig\u00f3rio","family":"Fialho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"5","key":"2001_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41434-020-0174-4","volume":"28","author":"I Trapani","year":"2021","unstructured":"Trapani I, Tornabene P, Auricchio A. Large gene delivery to the retina with AAV vectors: are we there yet? Gene Ther. 2021;28(5):220\u20132. https:\/\/doi.org\/10.1038\/s41434-020-0174-4","journal-title":"Gene Ther"},{"issue":"7","key":"2001_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.64.7.39","volume":"64","author":"S Drag","year":"2023","unstructured":"Drag S, Dotiwala F, Upadhyay AK. Gene therapy for retinal degenerative diseases: Progress, Challenges, and future directions. Invest Ophthalmol Vis Sci. 2023;64(7):39. https:\/\/doi.org\/10.1167\/iovs.64.7.39","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2001_CR3","doi-asserted-by":"crossref","unstructured":"Purdy R, John M, Bray A, Clare AJ, Copland DA, Chan YK et al. Gene Therapy-Associated uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy. Prog Retin Eye Res. 2025:101354.","DOI":"10.1016\/j.preteyeres.2025.101354"},{"issue":"1","key":"2001_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40259-023-00629-y","volume":"38","author":"BFM Castro","year":"2024","unstructured":"Castro BFM, Steel JC, Layton CJ. AAV-Based strategies for treatment of retinal and choroidal vascular diseases: advances in Age-Related macular degeneration and diabetic retinopathy therapies. BioDrugs. 2024;38(1):73\u201393. https:\/\/doi.org\/10.1007\/s40259-023-00629-y","journal-title":"BioDrugs"},{"key":"2001_CR5","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1017\/erm.2024.4","volume":"26","author":"B Castro","year":"2024","unstructured":"Castro B, Steel JC, Layton CJ. AAV-mediated gene therapies for glaucoma and uveitis: are we there yet? Expert Rev Mol Med. 2024;26:e9.","journal-title":"Expert Rev Mol Med"},{"issue":"8","key":"2001_CR6","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.drudis.2019.05.038","volume":"24","author":"T Bordet","year":"2019","unstructured":"Bordet T, Behar-Cohen F. Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives. Drug Discov Today. 2019;24(8):1685\u201393. https:\/\/doi.org\/10.1016\/j.drudis.2019.05.038","journal-title":"Drug Discov Today"},{"issue":"1","key":"2001_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40259-023-00629-y","volume":"38","author":"BF Castro","year":"2024","unstructured":"Castro BF, Steel JC, Layton CJ. AAV-based strategies for treatment of retinal and choroidal vascular diseases: advances in age-related macular degeneration and diabetic retinopathy therapies. BioDrugs. 2024;38(1):73\u201393.","journal-title":"BioDrugs"},{"key":"2001_CR8","doi-asserted-by":"publisher","unstructured":"Ren D, Fisson S, Dalkara D, Ail D. Immune responses to gene editing by viral and Non-Viral delivery vectors used in retinal gene therapy. Pharmaceutics. 2022;14(9). https:\/\/doi.org\/10.3390\/pharmaceutics14091973","DOI":"10.3390\/pharmaceutics14091973"},{"key":"2001_CR9","unstructured":"Foster T, Lim P, Wagle SR, Ionescu CM, Kovacevic B, McLenachan S et al. Nanoparticle-Based gene therapy strategies in retinal delivery. J Drug Target. 2024:1\u201320."},{"key":"2001_CR10","doi-asserted-by":"publisher","unstructured":"Bitoque DB, Fernandes CF, Oliveira AML, Silva GA. Strategies to improve the targeting of retinal cells by Non-Viral gene therapy vectors. Front Drug Delivery. 2022;2. https:\/\/doi.org\/10.3389\/fddev.2022.899260","DOI":"10.3389\/fddev.2022.899260"},{"issue":"8","key":"2001_CR11","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/mt.2011.304","volume":"20","author":"E Touchard","year":"2012","unstructured":"Touchard E, Berdugo M, Bigey P, El Sanharawi M, Savoldelli M, Naud MC, et al. Suprachoroidal electrotransfer: a nonviral gene delivery method to transfect the choroid and the retina without detaching the retina. Mol Ther. 2012;20(8):1559\u201370. https:\/\/doi.org\/10.1038\/mt.2011.304","journal-title":"Mol Ther"},{"issue":"1","key":"2001_CR12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s42003-023-04851-w","volume":"6","author":"M Kato","year":"2023","unstructured":"Kato M, Ishikawa S, Shen Q, Du Z, Katashima T, Naito M, et al. In situ-formable, dynamic crosslinked poly(ethylene glycol) carrier for localized adeno-associated virus infection and reduced off-target effects. Commun Biol. 2023;6(1):508. https:\/\/doi.org\/10.1038\/s42003-023-04851-w","journal-title":"Commun Biol"},{"key":"2001_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.omtm.2021.02.017","volume":"21","author":"A Remes","year":"2021","unstructured":"Remes A, Basha DI, Puehler T, Borowski C, Hille S, Kummer L, et al. Alginate hydrogel polymers enable efficient delivery of a vascular-targeted AAV vector into aortic tissue. Mol Ther Methods Clin Dev. 2021;21:83\u201393. https:\/\/doi.org\/10.1016\/j.omtm.2021.02.017","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"11","key":"2001_CR14","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1016\/j.biomaterials.2012.01.027","volume":"33","author":"SK Cho","year":"2012","unstructured":"Cho SK, Kwon YJ. Simultaneous gene transduction and Silencing using stimuli-responsive viral\/nonviral chimeric nanoparticles. Biomaterials. 2012;33(11):3316\u201323.","journal-title":"Biomaterials"},{"issue":"9","key":"2001_CR15","doi-asserted-by":"publisher","first-page":"8705","DOI":"10.1021\/acsnano.6b04155","volume":"10","author":"CA Hong","year":"2016","unstructured":"Hong CA, Cho SK, Edson JA, Kim J, Ingato D, Pham B, et al. Viral\/nonviral chimeric nanoparticles to synergistically suppress leukemia proliferation via simultaneous gene transduction and Silencing. ACS Nano. 2016;10(9):8705\u201314.","journal-title":"ACS Nano"},{"issue":"11","key":"2001_CR16","doi-asserted-by":"publisher","first-page":"14262","DOI":"10.1021\/acsnano.0c03850","volume":"14","author":"ML Lugin","year":"2020","unstructured":"Lugin ML, Lee RT, Kwon YJ. Synthetically engineered adeno-associated virus for efficient, safe, and versatile gene therapy applications. ACS Nano. 2020;14(11):14262\u201383.","journal-title":"ACS Nano"},{"issue":"23","key":"2001_CR17","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.3390\/jcm13237385","volume":"13","author":"O Siontas","year":"2024","unstructured":"Siontas O, Ahn S. Challenges in AAV-Based retinal gene therapies and the role of magnetic nanoparticle platforms. J Clin Med. 2024;13(23):7385.","journal-title":"J Clin Med"},{"issue":"3","key":"2001_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jconrel.2010.12.004","volume":"150","author":"SK Cho","year":"2011","unstructured":"Cho SK, Kwon YJ. Polyamine\/DNA polyplexes with acid-degradable polymeric shell as structurally and functionally virus-mimicking nonviral vectors. J Controlled Release. 2011;150(3):287\u201397.","journal-title":"J Controlled Release"},{"issue":"3","key":"2001_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jconrel.2005.02.027","volume":"105","author":"YJ Kwon","year":"2005","unstructured":"Kwon YJ, Standley SM, Goh SL, Fr\u00e9chet JM. Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles. J Controlled Release. 2005;105(3):199\u2013212.","journal-title":"J Controlled Release"},{"issue":"12","key":"2001_CR20","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","volume":"33","author":"H Koo","year":"2012","unstructured":"Koo H, Moon H, Han H, Na JH, Huh MS, Park JH, et al. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection. Biomaterials. 2012;33(12):3485\u201393. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.01.030","journal-title":"Biomaterials"},{"key":"2001_CR21","doi-asserted-by":"publisher","first-page":"100107","DOI":"10.1016\/j.crphar.2022.100107","volume":"3","author":"BFM Castro","year":"2022","unstructured":"Castro BFM, da Silva CN, Cordeiro LPB, de Freitas Cenachi SP, Vasconcelos-Santos DV, Machado RR, et al. Low-dose Melittin is safe for intravitreal administration and ameliorates inflammation in an experimental model of uveitis. Curr Res Pharmacol Drug Discovery. 2022;3:100107.","journal-title":"Curr Res Pharmacol Drug Discovery"},{"key":"2001_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-017-9621-y","volume":"136","author":"AG Robson","year":"2018","unstructured":"Robson AG, Nilsson J, Li S, Jalali S, Fulton AB, Tormene AP, et al. ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol. 2018;136:1\u201326.","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"2001_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","volume":"130","author":"DL McCulloch","year":"2015","unstructured":"McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, et al. ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015;130(1):1\u201312.","journal-title":"Doc Ophthalmol"},{"key":"2001_CR24","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00417-006-0506-0","volume":"245","author":"C Layton","year":"2007","unstructured":"Layton C, Safa R, Osborne N. Oscillatory potentials and the b-Wave: partial masking and interdependence in dark adaptation and diabetes in the rat. Graefe\u2019s Archive Clin Experimental Ophthalmol. 2007;245:1335\u201345.","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol"},{"issue":"4","key":"2001_CR25","doi-asserted-by":"publisher","first-page":"103670","DOI":"10.1016\/j.xphs.2025.01.006","volume":"114","author":"S Kundapura","year":"2025","unstructured":"Kundapura S, Craske D, Hickman G, Braim S. Enhanced SiRNA delivery with novel smart chitosan-based formulations. J Pharm Sci. 2025;114(4):103670. https:\/\/doi.org\/10.1016\/j.xphs.2025.01.006","journal-title":"J Pharm Sci"},{"issue":"2","key":"2001_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijpharm.2017.04.008","volume":"525","author":"G Cavallaro","year":"2017","unstructured":"Cavallaro G, Sardo C, Craparo EF, Porsio B, Giammona G. Polymeric nanoparticles for SiRNA delivery: production and applications. Int J Pharm. 2017;525(2):313\u201333. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.04.008","journal-title":"Int J Pharm"},{"key":"2001_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","volume":"144","author":"Y Dong","year":"2019","unstructured":"Dong Y, Siegwart DJ, Anderson DG. Strategies, design, and chemistry in SiRNA delivery systems. Adv Drug Deliv Rev. 2019;144:133\u201347. https:\/\/doi.org\/10.1016\/j.addr.2019.05.004","journal-title":"Adv Drug Deliv Rev"},{"key":"2001_CR28","doi-asserted-by":"publisher","first-page":"107102","DOI":"10.1016\/j.phrs.2024.107102","volume":"201","author":"MD Perez-Carrion","year":"2024","unstructured":"Perez-Carrion MD, Posadas I, Cena V. Nanoparticles and sirna: A new era in therapeutics? Pharmacol Res. 2024;201:107102. https:\/\/doi.org\/10.1016\/j.phrs.2024.107102","journal-title":"Pharmacol Res"},{"key":"2001_CR29","doi-asserted-by":"publisher","unstructured":"Yang B, Li G, Liu J, Li X, Zhang S, Sun F, et al. Nanotechnology for Age-Related macular degeneration. Pharmaceutics. 2021;13(12). https:\/\/doi.org\/10.3390\/pharmaceutics13122035","DOI":"10.3390\/pharmaceutics13122035"},{"issue":"9","key":"2001_CR30","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.3390\/molecules26092485","volume":"26","author":"W-H Chang","year":"2021","unstructured":"Chang W-H, Liu P-Y, Lin M-H, Lu C-J, Chou H-Y, Nian C-Y, et al. Applications of hyaluronic acid in ophthalmology and contact lenses. Molecules. 2021;26(9):2485.","journal-title":"Molecules"},{"key":"2001_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.colsurfb.2016.01.014","volume":"141","author":"W Zeng","year":"2016","unstructured":"Zeng W, Li Q, Wan T, Liu C, Pan W, Wu Z, et al. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Colloids Surf B Biointerfaces. 2016;141:28\u201335. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.01.014","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"8","key":"2001_CR32","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.drudis.2019.05.005","volume":"24","author":"X Huang","year":"2019","unstructured":"Huang X, Chau Y. Intravitreal nanoparticles for retinal delivery. Drug Discovery Today. 2019;24(8):1510\u201323.","journal-title":"Drug Discovery Today"},{"issue":"40","key":"2001_CR33","doi-asserted-by":"publisher","first-page":"15461","DOI":"10.1039\/C7NR03142D","volume":"9","author":"N-K Ryoo","year":"2017","unstructured":"Ryoo N-K, Lee J, Lee H, Hong HK, Kim H, Lee JB, et al. Therapeutic effects of a novel siRNA-based anti-VEGF (siVEGF) nanoball for the treatment of choroidal neovascularization. Nanoscale. 2017;9(40):15461\u20139.","journal-title":"Nanoscale"},{"issue":"6","key":"2001_CR34","first-page":"1038","volume":"11","author":"S Jiang","year":"2018","unstructured":"Jiang S, Franco YL, Zhou Y, Chen J. Nanotechnology in retinal drug delivery. Int J Ophthalmol. 2018;11(6):1038.","journal-title":"Int J Ophthalmol"},{"key":"2001_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biomaterials.2018.03.034","volume":"168","author":"D Huang","year":"2018","unstructured":"Huang D, Chen Y-S, Green CR, Rupenthal ID. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia. Biomaterials. 2018;168:10\u201323.","journal-title":"Biomaterials"},{"key":"2001_CR36","doi-asserted-by":"publisher","first-page":"7691","DOI":"10.2147\/IJN.S459905","volume":"19","author":"X Zhou","year":"2024","unstructured":"Zhou X, Liu J, Xiao S, Liang X, Li Y, Mo F, et al. Adeno-Associated virus engineering and load strategy for tropism Modification, immune evasion and enhanced transgene expression. Int J Nanomed. 2024;19:7691\u2013708. https:\/\/doi.org\/10.2147\/IJN.S459905","journal-title":"Int J Nanomed"},{"issue":"22","key":"2001_CR37","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1039\/d0bm01367f","volume":"8","author":"K Kaygisiz","year":"2020","unstructured":"Kaygisiz K, Synatschke CV. Materials promoting viral gene delivery. Biomater Sci. 2020;8(22):6113\u201356. https:\/\/doi.org\/10.1039\/d0bm01367f","journal-title":"Biomater Sci"},{"issue":"3","key":"2001_CR38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.taap.2015.10.008","volume":"289","author":"W Huang","year":"2015","unstructured":"Huang W, Collette W III, Twamley M, Aguirre SA, Sacaan A. Application of electroretinography (ERG) in early drug development for assessing retinal toxicity in rats. Toxicol Appl Pharmcol. 2015;289(3):525\u201333.","journal-title":"Toxicol Appl Pharmcol"},{"key":"2001_CR39","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1167\/iovs.03-1080","volume":"45","author":"HA H","year":"2004","unstructured":"HA H. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci. 2004;45:1002\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2001_CR40","doi-asserted-by":"crossref","unstructured":"Ramos MF, Attar M, Seals JR, Luhrs KA. Safety evaluation of ocular drugs. A comprehensive guide to toxicology in nonclinical drug development. 2024:879\u2013944.","DOI":"10.1016\/B978-0-323-85704-8.00031-1"},{"key":"2001_CR41","doi-asserted-by":"crossref","unstructured":"Chen J, Caspi RR. Clinical and functional evaluation of ocular inflammatory disease using the model of experimental autoimmune uveitis. Immunological Tolerance: Methods and Protocols. 2019:211\u2009\u2013\u200927.","DOI":"10.1007\/978-1-4939-8938-6_15"},{"issue":"3","key":"2001_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2131\/jts.40.295","volume":"40","author":"H Onodera","year":"2015","unstructured":"Onodera H, Sasaki S, Otake S, Tomohiro M, Shibuya K, Nomura M. General considerations in ocular toxicity risk assessment from the toxicologists\u2019 viewpoints. J Toxicol Sci. 2015;40(3):295\u2013307.","journal-title":"J Toxicol Sci"},{"key":"2001_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.omtn.2019.01.012","volume":"16","author":"AL Askou","year":"2019","unstructured":"Askou AL, Alsing S, Benckendorff JNE, Holmgaard A, Mikkelsen JG, Aagaard L, et al. Suppression of choroidal neovascularization by AAV-Based Dual-Acting antiangiogenic gene therapy. Mol Ther Nucleic Acids. 2019;16:38\u201350. https:\/\/doi.org\/10.1016\/j.omtn.2019.01.012","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"2001_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/fcp.12561","volume":"35","author":"J Jiang","year":"2021","unstructured":"Jiang J, Zhang X, Tang Y, Li S, Chen J. Progress on ocular SiRNA gene-silencing therapy and drug delivery systems. Fundam Clin Pharmacol. 2021;35(1):4\u201324. https:\/\/doi.org\/10.1111\/fcp.12561","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"2001_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ymthe.2024.01.005","volume":"32","author":"M Moazzam","year":"2024","unstructured":"Moazzam M, Zhang M, Hussain A, Yu X, Huang J, Huang Y. The landscape of nanoparticle-based SiRNA delivery and therapeutic development. Mol Ther. 2024;32(2):284\u2013312. https:\/\/doi.org\/10.1016\/j.ymthe.2024.01.005","journal-title":"Mol Ther"}],"updated-by":[{"DOI":"10.1007\/s13346-026-02048-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000}}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02001-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-02001-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02001-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:49:42Z","timestamp":1772549382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-02001-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2001"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-02001-9","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13346-026-02048-2","URL":"https:\/\/doi.org\/10.1007\/s13346-026-02048-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish this article in Drug Delivery and Translational Research.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}